Please login to the form below

Not currently logged in
Email:
Password:

Executive vice president of Biogen leaves

Tony Kingsley departs the firm

Biogen's executive vice president of global commercial operations has left the company and a search has been initiated for his replacement.

During the interim period, his responsibilities will be assumed by John Cox who is executive VP of pharmaceutical operations and technology.

George Scangos, CEO at Biogen, said: “Tony has made significant contributions to Biogen. He led the successful introduction of five important new products and helped serve patients around the world with our life-transforming therapies. All of us wish Tony the best in his future endeavours.”

Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

Scangos added: “We are pleased that John will lead our commercial operations on an interim basis. His 12 years at Biogen and in-depth knowledge our pharmaceutical and commercial operations give us great confidence that we will continue to execute on the commercial opportunities at-hand as we search for a permanent leader.”

23rd October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics